Skip to main content
Fig. 11 | Virology Journal

Fig. 11

From: Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment

Fig. 11

Illustrates the expression levels of recombinant proteins and their specific reactions with monoclonal antibodies, specifically VP1VP2 and VP2 alone, in Sf9 cells that were infected with recBacmid BPV: VP2 and recBacmid BPV: VP1VP2 at different time points. In all the panels the first in the left column represents the mock (cell only) as negative control. At 24-, 48-, and 72-hours post-transfection, the first panel displays the cells infected only with recBacmid BPVVP2 without His-tag, together with the level of expressed VP2 recombinant protein identified with mAb. b The second panel used anti-DE-loop rabbit monoclonal antibodies to identify His-tagged and His-Tag free VP1VP2 and VP2 protein expression levels. c The third panel displayed the expression levels of proteins from His-tagged and His-Tag free VP1VP2 and VP2 that were detected with anti-anti-His-Tag mouse monoclonal antibodies. These proteins were His-tagged and His-Tag free. In this experiment, RFP (red fluorescence antibodies) Alexa-Fluor®-594-conjugated anti-rabbit IgG and antimouse secondary antibodies were used. Generally, the reaction in the fluorescence microscope clearly shows that the rec-proteins from different designs vary in expression at different time points, and the mAbs are highly specific in the detection of the target proteins

Back to article page